Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Yield10 Bioscience

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Yield10 Bioscience Earnings Perspective: Return On Capital Employed

Yield10 Bioscience Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Yield10 Bioscience (NASDAQ:YTEN) reported Q1 sales of $149.00 thousand. Earnings fell to a loss of $3.33 million, resulting in a 11.78% decrease from last quarter.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Yield10 Bioscience: Q1 Earnings Insights

Yield10 Bioscience (NASDAQ:YTEN) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Yield10 Bioscience Earnings Preview

Yield10 Bioscience (NASDAQ:YTEN) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Yield10 Bioscience will report an earnings per share (EPS) of $-0.65.

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

Recap: Yield10 Bioscience Q4 Earnings

Recap: Yield10 Bioscience Q4 Earnings

Yield10 Bioscience (NASDAQ:YTEN) reported its Q4 earnings results on Wednesday, March 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Preview: Yield10 Bioscience's Earnings

Preview: Yield10 Bioscience's Earnings

Yield10 Bioscience (NASDAQ:YTEN) is set to give its latest quarterly earnings report on Wednesday, 2022-03-09. Here's what investors need to know before the announcement. Analysts estimate that Yield10 Bioscience will report an earnings per share (EPS) of $-0.63.

Organisations

Vertex Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play